A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer
Authors
Keywords
-
Journal
Proteomics Clinical Applications
Volume 5, Issue 7-8, Pages 383-396
Publisher
Wiley
Online
2011-04-20
DOI
10.1002/prca.201000115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- (2010) Brendan MacLean et al. BIOINFORMATICS
- Untangling the unfolded protein response
- (2010) Emma L. Davenport et al. CELL CYCLE
- Phase I Pharmacokinetic and Pharmacodynamic Study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an Inhibitor of Heat-Shock Protein 90, in Patients With Advanced Solid Tumors
- (2010) Ramesh K. Ramanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Quantitative Analysis of Proteome Coverage and Recovery Rates for Upstream Fractionation Methods in Proteomics
- (2010) Yuan Fang et al. JOURNAL OF PROTEOME RESEARCH
- Quantification of β-Catenin Signaling Components in Colon Cancer Cell Lines, Tissue Sections, and Microdissected Tumor Cells using Reaction Monitoring Mass Spectrometry
- (2010) Yi Chen et al. JOURNAL OF PROTEOME RESEARCH
- Workflow Comparison for Label-Free, Quantitative Secretome Proteomics for Cancer Biomarker Discovery: Method Evaluation, Differential Analysis, and Verification in Serum
- (2010) Sander R. Piersma et al. JOURNAL OF PROTEOME RESEARCH
- Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
- (2010) J E Lancet et al. LEUKEMIA
- Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
- (2010) E. S. Park et al. MOLECULAR CANCER THERAPEUTICS
- Serial dilution curve: a new method for analysis of reverse phase protein array data
- (2009) L. Zhang et al. BIOINFORMATICS
- Transcription Inhibition of Heat Shock Proteins: A Strategy for Combination of 17-Allylamino-17-Demethoxygeldanamycin and Actinomycin D
- (2009) F. Cervantes-Gomez et al. CANCER RESEARCH
- Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
- (2009) Shivaani Kummar et al. EUROPEAN JOURNAL OF CANCER
- The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines
- (2009) Jennifer K. McCleese et al. INTERNATIONAL JOURNAL OF CANCER
- Expediting the Development of Targeted SRM Assays: Using Data from Shotgun Proteomics to Automate Method Development
- (2009) Amol Prakash et al. JOURNAL OF PROTEOME RESEARCH
- Comparison of Extensive Protein Fractionation and Repetitive LC-MS/MS Analyses on Depth of Analysis for Complex Proteomes
- (2009) Huan Wang et al. JOURNAL OF PROTEOME RESEARCH
- A Human Proteome Detection and Quantitation Project
- (2009) N. Leigh Anderson et al. MOLECULAR & CELLULAR PROTEOMICS
- Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma
- (2009) Michael A. Kuzyk et al. MOLECULAR & CELLULAR PROTEOMICS
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
- (2009) Terri A Addona et al. NATURE BIOTECHNOLOGY
- SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK
- (2008) Y. Okawa et al. BLOOD
- HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma
- (2008) Ramadevi Nimmanapalli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells
- (2008) Pascale Flandrin et al. CELL STRESS & CHAPERONES
- Targeting Akt and Heat Shock Protein 90 Produces Synergistic Multiple Myeloma Cell Cytotoxicity in the Bone Marrow Microenvironment
- (2008) A. Huston et al. CLINICAL CANCER RESEARCH
- Heat Shock Protein 90 as a Drug Target: Some Like It Hot
- (2008) U. Banerji CLINICAL CANCER RESEARCH
- Implementation of a data repository-driven approach for targeted proteomics experiments by multiple reaction monitoring
- (2008) Geraldine M. Walsh et al. Journal of Proteomics
- Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma
- (2008) T Stühmer et al. LEUKEMIA
- Coupled Global and Targeted Proteomics of Human Embryonic Stem Cells during Induced Differentiation
- (2008) Anastasia K. Yocum et al. MOLECULAR & CELLULAR PROTEOMICS
- Proteomic Contributions to Personalized Cancer Care
- (2008) John M. Koomen et al. MOLECULAR & CELLULAR PROTEOMICS
- Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer
- (2008) Dongweon Song et al. MOLECULAR CANCER THERAPEUTICS
- A database of mass spectrometric assays for the yeast proteome
- (2008) Paola Picotti et al. NATURE METHODS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search